Enliven Therapeutics
Price & Volume
Stats
See more52W Range | $9.80-$30.03 |
Market Cap | $1.1B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.89 |
News
See moreYahoo Finance • 3 months ago
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
Yahoo Finance • last year
Enliven Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update
About
CEO | Mr. Samuel S. Kintz M.B.A. |
CFO | Mr. Benjamin Hohl |
Address | 6200 Lookout Road, Boulder, CO, United States, 80301 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 46 |
